Home/Filings/4/0001615219-18-000004
4//SEC Filing

Wessel Thomas 4

Accession 0001615219-18-000004

CIK 0001615219other

Filed

Jan 18, 7:00 PM ET

Accepted

Jan 19, 9:43 AM ET

Size

5.2 KB

Accession

0001615219-18-000004

Insider Transaction Report

Form 4
Period: 2018-01-17
Wessel Thomas
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2018-01-17+100,000100,000 total
    Exercise: $3.98Exp: 2028-01-17Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]The stock option will vest in 48 successive equal monthly installments measured from January 17, 2018.

Issuer

Flex Pharma, Inc.

CIK 0001615219

Entity typeother

Related Parties

1
  • filerCIK 0001456055

Filing Metadata

Form type
4
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 9:43 AM ET
Size
5.2 KB